Chronic Phase Chronic Myelogenous Leukemia Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

IndicationStatusPhase
DBCOND0028870 (Chronic Phase Chronic Myelogenous Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01093586Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT01056614Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesTreatment